Skip to main content

Pharming Group N.V. (PHAR)

NASDAQ: PHAR · IEX Real-Time Price · USD
9.59 -0.15 (-1.54%)
Oct 21, 2021 11:26 AM EDT - Market open
Market Cap613.76M
Revenue (ttm)226.46M
Net Income (ttm)40.29M
Shares Out64.00M
EPS (ttm)0.59
PE Ratio16.38
Forward PEn/a
Ex-Dividend Daten/a
Previous Close9.74
Day's Range9.51 - 9.59
52-Week Range9.02 - 21.99
Price Targetn/a
Est. Earnings Daten/a

About PHAR

Pharming Group N.V., a specialty pharmaceutical company, develops products for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment of pre- eclampsia, acute kidney injury, and COVID-19; leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) to treat patients with activated activated ...

CEOSijmen de Vries
Stock ExchangeNASDAQ
Ticker SymbolPHAR
Full Company Profile

Financial Performance

In 2020, Pharming Group's revenue was 185.69 million, an increase of 9.86% compared to the previous year's 169.02 million. Earnings were 33.04 million, a decrease of -8.73%.

Financial numbers in millions EURFinancial Statements


Pharming Group announces ADSs admitted to trade on Nasdaq under the symbol "PHAR"

Pharming Group N.V. (Euronext Amsterdam: PHARM) announces that, effective today, its American Depositary Shares ("ADSs") have been admitted for listing on the Nasdaq Global Market ("Nasdaq") under the s...

9 months ago - PR Newswire

Pharming Group Publicly Files Registration Statement with the U.S. SEC to Facilitate Listing of ADSs Representing Ord...

Pharming Group N.V., a global, commercial stage biopharmaceutical company developing innovative protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical...

10 months ago - PR Newswire UK

Pharming Group N.V. IPO Registration Document (S-1)

Pharming Group N.V. has filed to go public with an IPO on the NASDAQ.

10 months ago - SEC